United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018


January 7, 2013
155 Pages - SKU: GMD4939664
License type:
Table of Contents Search inside this report Related Reports
Countries covered: United Arab Emirates
United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

Summary

Global Markets Direct’s new report, ”United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope
  • Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the United Arab Emirates In Vitro Diagnosticsmarket.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the United Arab Emirates In Vitro Diagnostics competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In United Arab Emirates
3.1 In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018
3.2 In Vitro Diagnostics, United Arab Emirates, Company Share (2010-2011)
4 Clinical Chemistry In United Arab Emirates
4.1 Clinical Chemistry Overall Revenue, (2004-2018)
4.1.1 Clinical Chemisty Analyzers, Revenue (2004-2018)
4.1.2 Urine Analysis, Revenue (2004-2018)
4.2 Clinical Chemistry Distribution Share (2010-2011)
4.3 Clinical Chemistry, United Arab Emirates, Company Share (2010-2011)
5 Genetic Testing In United Arab Emirates
5.1 Genetic Testing Overall Revenue, (2004-2018)
5.2 Genetic Testing Distribution Share (2010-2011)
5.3 Genetic Testing, United Arab Emirates, Company Share (2010-2011)
6 Haematology In United Arab Emirates
6.1 Haematology Overall Revenue, (2004-2018)
6.1.1 Haematology Reagents, Revenue, (2004-2018)
6.1.2 Immunohaematology, Revenue (2004-2018)
6.1.3 Haemostasis, Revenue (2004-2018)
6.1.4 Haematology Rapid Tests, Revenue (2004-2018)
6.1.5 Haematology Cell Counters, Revenue (2004-2018)
6.2 Haematology Distribution Share (2010-2011)
6.3 Haematology, United Arab Emirates, Company Share (2010-2011)
7 Histology And Cytology In United Arab Emirates
7.1 Histology And Cytology Overall Revenue, (2004-2018)
7.2 Histology And Cytology Distribution Share (2010-2011)
7.3 Histology And Cytology, United Arab Emirates, Company Share (2010-2011)
8 Immuno Chemistry In United Arab Emirates
8.1 Immuno Chemistry Overall Revenue, (2004-2018)
8.1.1 Disease Specific Immunochemistry, Revenue (2004-2018)
8.1.2 Drugs of Abuse / Toxicology, Revenue (2004-2018)
8.1.3 Endocrinology Tests, Revenue (2004-2018)
8.1.4 Immunochemistry Rapid Tests, Revenue (2004-2018)
8.1.5 Therapeutic Drug Monitoring, Revenue (2004-2018)
8.1.6 Immunochemistry Analyzers, Revenue (2004-2018)
8.2 Immuno Chemistry Distribution Share (2010-2011)
8.3 Immuno Chemistry, United Arab Emirates, Company Share (2010-2011)
9 Infectious Immunology In United Arab Emirates
9.1 Infectious Immunology Overall Revenue, (2004-2018)
9.1.1 Infectious Immunology Rapid Tests, Revenue (2004-2018)
9.2 Infectious Immunology Distribution Share (2010-2011)
9.3 Infectious Immunology, United Arab Emirates, Company Share (2010-2011)
10 Microbiology Culture In United Arab Emirates
10.1 Microbiology Culture Overall Revenue, (2004-2018)
10.1.1 Microbiology Analyzers, Revenue (2004-2018)
10.2 Microbiology Culture Distribution Share (2010-2011)
10.3 Microbiology Culture, United Arab Emirates, Company Share (2010-2011)
11 Overview of Key Companies in United Arab Emirates In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.2 Siemens Healthcare
11.2.1 Company Overview
11.3 Beckman Coulter, Inc.
11.3.1 Company Overview
11.4 Abbott Laboratories
11.4.1 Company Overview
11.5 Ortho-Clinical Diagnostics Inc.
11.5.1 Company Overview
11.6 bioMerieux S.A.
11.6.1 Company Overview
11.7 ELITech Group
11.7.1 Company Overview
11.8 Becton, Dickinson and Company
11.8.1 Company Overview
11.9 Alere Inc.
11.9.1 Company Overview
11.10 Mindray Medical International Limited
11.10.1 Company Overview
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Company Overview
11.12 PerkinElmer, Inc.
11.12.1 Company Overview
11.13 Sysmex Corporation
11.13.1 Company Overview
11.14 Thermo Fisher Scientific Inc.
11.14.1 Company Overview
11.15 Horiba, Ltd.
11.15.1 Company Overview
11.16 Grifols, S.A.
11.16.1 Company Overview
11.17 DiaSorin S.p.A
11.17.1 Company Overview
11.18 Qiagen N.V.
11.18.1 Company Overview
11.19 Gen-Probe Incorporated
11.19.1 Company Overview
11.20 Diagnostica Stago, Inc.
11.20.1 Company Overview
11.21 Life Technologies Corporation
11.21.1 Company Overview
11.22 Hologic, Inc.
11.22.1 Company Overview
11.23 Immucor, Inc.
11.23.1 Company Overview
11.24 Chembio Diagnostics, Inc.
11.24.1 Company Overview
11.25 Phadia AB
11.25.1 Company Overview
12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Definitions of Markets Covered in the Report
12.2.1 In Vitro Diagnostics
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panel Validation
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer
1.1 List of Tables
Table 1: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 3: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 4: In Vitro Diagnostics, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 5: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 6: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 7: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 8: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 9: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 10: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 11: Clinical Chemistry, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Clinical Chemistry, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 14: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 15: Genetic Testing, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Genetic Testing, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 17: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 20: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 21: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 22: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 23: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 24: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 25: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 26: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 27: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 28: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 29: Haematology, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Haematology, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 31: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 32: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 33: Histology And Cytology, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 34: Histology And Cytology, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 35: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 36: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 37: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 38: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 39: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 40: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 41: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 42: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 43: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 44: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 45: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 46: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 47: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 48: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 49: Immuno Chemistry, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Immuno Chemistry, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 52: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 53: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 54: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 55: Infectious Immunology, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 56: Infectious Immunology, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 58: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 59: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 60: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 61: Microbiology Culture, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 62: Microbiology Culture, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
1.2 List of Figures
Figure 1: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018
Figure 2: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 3: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 4: In Vitro Diagnostics, United Arab Emirates, Company Share (%), 2011
Figure 5: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 6: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 7: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 8: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 9: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 10: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 11: Clinical Chemistry, United Arab Emirates, Company Share (%), 2011
Figure 12: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: Genetic Testing, United Arab Emirates, Company Share (%), 2011
Figure 15: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 16: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 17: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 18: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 19: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 20: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 21: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 22: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 23: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 24: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 25: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 26: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 27: Haematology, United Arab Emirates, Company Share (%), 2011
Figure 28: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 29: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 30: Histology And Cytology, United Arab Emirates, Company Share (%), 2011
Figure 31: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 32: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 33: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 34: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 35: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 36: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 37: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 38: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 39: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 40: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 41: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 42: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 43: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 44: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 45: Immuno Chemistry, United Arab Emirates, Company Share (%), 2011
Figure 46: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 47: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 48: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 49: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 50: Infectious Immunology, United Arab Emirates, Company Share (%), 2011
Figure 51: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 52: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 53: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 54: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 55: Microbiology Culture, United Arab Emirates, Company Share (%), 2011
Figure 56: Global Markets Direct Methodology

More Hematology & Oncology reports by Global Markets Direct

Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 by Global Markets Direct
Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, ”Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to ...
Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 by Global Markets Direct
Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, ”Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to ...
Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 by Global Markets Direct
Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, ”Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to ...
Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 by Global Markets Direct
Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, ”Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to ...
See all reports like this >>

More United Arab Emirates reports

Country Risk Service United Arab Emirates January 2013 Updater by Economist Intelligence Unit
Country Risk Service is a comprehensive two-year forecasting service that monitors risks in 100 key emerging markets. It is designed for commercial bankers, institutional investors ...
D&B Country RiskLine Report: The United Arab Emirates by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United Arab Emirates by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United Arab Emirates January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
See all reports like this >>

 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Related Markets


Hematology & Oncology Reports

 
 

Share this report


Other tasks

 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!